MRMDOTCMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
MARIMED INC.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$0.06−0.00 (-3.39%)
Close on Oct 19, 2026
- Market cap
- $22.78M
- P/E (TTM)
- –
- Dividend yield
- –
Share price
−$0.0957 (−62.67%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.Earnings
MARIMED INC. grew revenue 4.4% to $163.82M over the twelve months to Jun 30, 2026. Free cash flow was $8.01M.
Revenue
$163.82M
+4.4% vs. a year earlier
Operating income
-$2.38M
TTM Q2 2026
Free cash flow
$8.01M
TTM Q2 2026
EPS, diluted
-$0.04
TTM Q2 2026
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026
Valuation
- Market cap
- $22.78M
- P/E ratio
- –
- Price to sales
- 0.14
- Price to book
- –
- Dividend yield
- –
- Free cash flow yield
- 35.17%
Fundamentals
- Revenue
- $163.82M
- Net income
- -$14.95M
- EPS, diluted
- -$0.04
- Free cash flow
- $8.01M
- Diluted shares
- 400M
Fifteen years at a glance
Fiscal years 2011 to 2025 and trailing twelve months, USD
Revenue
$163.82M+4.4% YoY
Gross profit
$58.37M-3.5% YoY
Operating income
-$2.38M
Net income
-$14.95M
EPS, diluted
-$0.04
Free cash flow
$8.01M
Reported periodTrailing twelve months